SCHEMBL13962116

SCHEMBL13962116

Cc1nc(/N=N/c2ccc(Cl)c([N+](=O)[O-])c2)c(COP(=O)(O)O)c(C=O)c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY1 P47900 4/20 1.00
▸ P2RY13 Q9BPV8 4/20 1.00
▸ PLA2G2A P14555 1/20 1.00
▸ MEN1 O00255 4/20 0.64
▸ KMT2A Q03164 4/20 0.64
▸ THRB P10828 3/20 0.64
▸ RECQL P46063 3/20 0.64
▸ MAPT P10636 6/20 0.64
▸ TDP1 Q9NUW8 6/20 0.64
▸ KDM4E B2RXH2 4/20 0.64
▸ P2RX7 Q99572 3/20 0.64
▸ HPGD P15428 3/20 0.64
▸ HSD17B10 Q99714 3/20 0.64
▸ ALDH1A1 P00352 2/20 0.64
▸ MAPK1 P28482 2/20 0.64
▸ CYP2D6 P10635 1/20 0.64
▸ ALOX15 P16050 1/20 0.64
▸ ALOX12 P18054 1/20 0.64
▸ BRCA1 P38398 1/20 0.64
▸ YWHAG P61981 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3361087 0.85 P2RY1 (1.00) P2RY1P2RY13PLA2G2AMEN1KMT2A
SCHEMBL13961829 0.85 P2RY1 (1.00) P2RY1P2RY13PLA2G2AMEN1KMT2A
SCHEMBL13961828 0.85 P2RY1 (0.74) P2RY1P2RY13PLA2G2AMEN1KMT2A
SCHEMBL3361094 0.84 P2RY1 (0.98) P2RY1P2RY13PLA2G2AMEN1KMT2A
SCHEMBL13961318 0.84 P2RY1 (0.73) P2RY1P2RY13PLA2G2AMEN1KMT2A
Water SCHEMBL31722292 0.84 P2RY1 (0.97) P2RY1P2RY13PLA2G2AMEN1KMT2A
SCHEMBL7091376 0.83 P2RY1 (0.71) P2RY1P2RY13PLA2G2AMEN1KMT2A
SCHEMBL7091071 0.83 P2RY1 (0.73) P2RY1P2RY13PLA2G2AMEN1KMT2A
SCHEMBL7094651 0.79 P2RX7 (0.74) P2RY1P2RY13PLA2G2AMEN1KMT2A
SCHEMBL7090990 0.79 P2RX7 (0.74) P2RY1P2RY13PLA2G2AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009005469-A2 THE USE OF COMPOUNDS SUCH AS PYRIDOXAL DERIVATIVES FOR THE TREATMENT OF DIABETES OR DISEASES ASSOCIATED WITH THE METABOLIC SYNDROME ERLINGE DAVID (SE) 2009-01-08 — — WO disclosed
Send feedback